Department of Surgery

Welcome to the Department of Surgery (2)
We are Specialists in Cardiovascular,
Breast/Endocrine, and Thoracic Surgery.

HOME > Academic Activities > Research Articles

Academic Activities

Breast and Endocrine Surgery

  • 【2017】
  • 1) Shibata T, Watari K, Izumi H, Kawahara A, Hattori S, Fukumitsu C, Murakami Y, Takahashi R, Toh U, Ito K, Ohdo S, Tanaka M, Kage M, Kuwano M, Ono M.
    Breast cancer resistance to antiestrogens is enhanced by increased ER degradation and ERBB2 expression. Cancer Res. 77: 545-56, 2017
  • 2) Ito Y, Onoda N, Ito K, Sugitani I, Takahashi S, Yamaguchi I, Kabu K, Tsukada K.
    Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Thyroid. 27: 1142-1148, 2017
  • 3) Iesato A, Nakamura T, Izumi H, Uehara T, Ito K.
    PATZ1 knockdown enhances malignant phenotype in thyroid epithelial follicular cells and thyroid cancer cells. Oncotarget. 8: 82754-82772, 2017
  • 4) Iesato A, Oba T, Ono K, Watanabe T, Ito T, Kanai T, Maeno K, Ito K.
    Case of painless thyroiditis that developed during adjuvant chemotherapy for breast cancer. Intl Canc Conf J. 6(4): 184-187, 2017
  • 5) Oba T, Maeno K, Ono M, Iesato A, Ito T, Kanai T, Mochizuki Y, Ito K, Yoshizawa A, Takayama F.
    A case of adenomyoepithelioma of the breast showing strong uptake of 18F-fluorodeoxyglucose on a positoron emission tomography. The Breast J. 23(2): 220-224, 2017
  • 6) Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K.
    Chylous leakage after axillary lymph node dissection in a patient with breast cancer The Breast J. [Epub ahead of print]
  • 【2016】
  • 1) Shibata T, Watari K, Izumi H, Kawahara A, Hattori S, Fukumitsu C, Murakami Y, Takahashi R, Toh U, Ito K, Ohdo S, Tanaka M, Kage M, Kuwano M, Ono M.
    Breast cancer resistance to antiestrogens is enhanced by increased ER degradation and ERBB2 expression.
    Cancer Res. 2016 Nov 22. [Epub ahead of print]
  • 2) Takazawa Y, Edamitsu T, Maeno K, Ogawa E, Uhara H, Kawachi S, Ito K, Okuyama R.
    5-Hydroxymethylcytosine as a putative marker for erosive adenomatosis of the nipple.
    J Dermatology. 43: 579-80, 2016
  • 3) Onoda N, Sugino K, Higashiyama T, Kammori M, Toda K, Ito K, Yoshida A, Suganuma N, Nakashima N, Suzuki S, Tsukahara K, Noguchi H, Koizumi M, Nemoto T, Hara H, Miyauchi A, Sugitani I.
    The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study.
    Thyroid. 26(9): 1293-1299, 2016
  • 4) Ito Y, Suzuki S, Ito K, Imai T, Okamoto T, Kitano H, Sugitani I, Sugino K, Tsutsui H, Hara H, Yoshida A, Shimizu K.
    Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma.
    Endocr J. 63(7): 597-602, 2016
  • 5) Maeno K, Ito T, Koyama H, Kanai T, Mochizuki Y, Ito K.
    Significance of sentinel lymph nodes with low gamma counts in breast cancer patients via radioisotopic sentinel lymph node biopsy.
    Arch Surg Oncol. 2: 1, 2016
  • 6) Hanamura T, Ito T, Kanai T, Maeno K, Shimojo Y, Uehara T, Suzuki T, Hayashi S, Ito K.
    Human 3 β - hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations.
    Cancer Med. 5(7): 1405-1415, 2016
  • 7) Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F.
    Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor:Report of a case and review of the literature.
    Onco Targets Ther. 9: 1641-1646, 2016.
  • 8) Oba T, Maeno K, Ono M, Iesato A, Ito T, Kanai T, Mochizuki Y, Ito K, Yoshizawa A, Takayama F.
    A case of adenomyoepithelioma of the breast showing strong uptake of 18F-fluorodeoxyglucose on a positoron emission tomography.
    The Breast J [Epub ahead of print]
  • 9) Oba T, Izumi H, Ito K
    ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines.
    Oncotarget. 7(43): 70011-70027, 2016
  • 【2015】
  • 1) Wu Y, Wang KY, Li Z, Liu YP, Izumi H, Yamada S, Uramoto H, Nakayama Y, Ito K, Kohno K.
    Y-box binding protein 1 expression in gastric cancer subtypes and association with cancer 57 neovasculature.
    ClinTransl Oncol.17(2):152-159,2015
  • 2) Onoda N, Sugitani I, Higashiyama T, Hara H, Ito K, Kammori M, Sugino K, Suzuki S, Toda K, Yoshida A, Miyauchi A.
    Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2).
    BMC Cancer. 15:475,2015.
  • 3) Ito T, Shingu K, Maeda C, Kitazawa M, Mizukami Y, Hiraguri M, Horigome N, Kaneko G, Itoh N, Ito K.
    Acute airway obstruction due to benign asymptomatic nodular goiter in the cervical region:Report of a case.
    Oncol Lett.10(3):1453-1455,2015
  • 4) Hanamura T, Ito K, Uehara T, Fukushima T, Sasaki S, Koizumi T.
    Chemosensitivity in Carcinoma Showing Thymus-Like Differentiation: A Case Report and Review of the Literature.
    Thyroid.25(8):969-972,2015
  • 【2014】
  • 1) Okada T, Nakamura T, Watanabe T, Onoda N, Ashida A, Okuyama R, Ito K.
    Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma.
    PLoS One. 9(4)e94487, 2014
  • 2) Sugishita Y, Kammori M, Yamada O, Yamazaki K, Ito K, Fukumori T, Yoshikawa K, Yamada T.
    Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of
    telomere length and hTERT expression.
    Ann Sug Oncol. 21(7):2318-2325, 2014
  • 3) Iesato A, Oba T, Ono M,Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ishizuka K,
    Kitabatake H, Takeuchi D, Suzuki A, Nakayama J, ITo K.
    Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the
    literature.
    Onco Targets and Therapy. 8:91-97, 2014
  • 4)Hanamura T,Niwa T, Gohno T, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S.
    Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
    Breast Cancer Res Treat. 2014;143:69-80.
  • 【2013】
  • 1)Mochizuki Y, Ito K, Izumi H, Kohno K, Amano J.
    Expression of Polypeptide N-acetylgalactosaminyl Transferase-3 and its Association with Clinicopathological Factors in Thyroid Carcinomas.
    Thyroid. 2013 ;23:1553-60.
  • 2)Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S.
    Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible
    aromatase inhibitor-resistance mechanism.
    Breast Cancer Res Treat.139(3):731-740, 2013
  • 3)Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K.
    Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.
    OncoTargets and Therapy. 6:1393-1398, 2013
  • 【2012】
  • 1) Ito T, Kamijo S, Izumi H, Kohno K, Amano J,Ito K.
    Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor positive breast cancer. Breast Cancer Res Treat. 133 (1): 145-159, 2012
  • 2) Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M Ito T, Koyama H, Kanai T,Maeno K, Mochizuki Y, Amano J.
    Multimodality Therapeutic Outcomes to Anaplastic Thyroid Carcinoma.
    An Improved Survival in Subgroups of Patients with Localized Primary Tumors.
    Head Neck. 34 (2):230-237, 2012
  • 3) Koyama H, Tiangang Zhuang, Jennifer E Light, Venkatadri Kolla, Higashi M,Patrick W McGrady, Wendy B London, Garrett M Brodeur. Mechanisms of CHD5 inactivation in neuroblastomas.
    Clin Cancer Res.18 (6):1588-1597, 2012
  • 4) Hyogotani A, Ito K, Yoshida K, Izumi H, Kohno K, Amano J.
    Association of Nuclear YB-1 Localization with LRP and EGFR Expression in Lung Cancer.
    Clin Lung Cancer. 13 (5): 375-384, 2012
  • 【2011】
  • 1) Fujita T, Murayama K, Hanamura T, Okada T, Ito T, Harada M, Komatsu A, Koyama H, Kanai T, Maeno K, Mochizuki Y, Hama Y, Ito K, Amano J, Fujimori M.:CSLEX (Sialyl Lewis X) is a useful tumor marker for monitoring of breast cancer patients. Jpn J Clin Oncol. 41(3):394-399, 2011
  • 2) Ito T, Ito K, Okada T, Murayama K, Hanamura T, Kanai T, Maeno K, Mochizuki Y, Kondo R, Amano J, Osada Y, Asano K.:Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor. Int J Clin Oncol. 16(2):156-160, 2011
  • 【2010】
  • Ito T, Okada T, Murayama K, Hanamura T, Kanai T, Mochizuki Y, Amano J, Ito K.:Two cases of sarcoidosis discovered accidentally by positron emission tomography in patients with breast cancer. Breast J. 16(5):561-563, 2010
  • 【2009】
  • 1) Ito K, Ito T, Okada T, Watanabe T, Gomi K, Kanai T, Mochizuki Y, Amano J:A Case of Brain Metastases from Breast Cancer that Responded to Anastrozole Monotherapy. The Breast Journal 15(4):435-437, 2009
  • 2) Kanai T, Amakawa M, Kato R, Shimizu K, Nakamura K, Ito K, Hama Y, Fujimori M, Amano J:Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma. Clin Chem Lab Med. 47(10):1285-1290, 2009
  • 3) Maeno K, Nakajima A, Conseil G, Rothnie A, Deeley RG, Cole SP.:Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1) Drug Metab Dispos. 37(7):1411-1420, 2009
  • 【2008】
  • 1) Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, Kolla V, Kim J, Zhao H, Pawel BR, London WB, Maris JM, White PS, Brodeur GM.:CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst. 100(13):940-949, 2008
  • 2) Ito K, Kanai T, Gomi K, Watanabe T, Ito T, Komatsu A, Fujita T, Amano J.:Endoscopic-assisted skin-sparing mastectomy combined with sentinel node biopsy. ANZ J Surg. 78(10):894-898, 2008
  • 3) Komatsu A, Nagasaki K, Fujimori M, Amano J, Miki Y.:Identification of novel deletion polymorphisms in breast cancer. Int J Oncol. 33(2):261-270, 2008
  • 4) Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y, Sano K, Fujimori M, Amano J, Ohhashi T, Kannagi R, Kimata K, Taniguchi S, Itano N.:Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol. 172(1):179-193, 2008